You are here: Industry Insights > Market News > SII gets purchase order from government for 10 crore doses of Covishield

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Riociguat(625115-55-1)

Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate

2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine(428854-24-4)

4,6-PyriMidinediaMine, 2-[1-[(2-fluorophenyl)Methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(phenylazo)-

1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1)

1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide(256376-68-8)

SII gets purchase order from government for 10 crore doses of Covishield

expresspharmaMarch 19, 2021

Tag: SII , Covishield , COVID-19 vaccine , AstraZeneca

Favorites

Serum Institute of India (SII) has received a new purchase order from the Government of India for the supply of 10-crore doses of the Oxford-AstraZeneca COVID-19 vaccine — Covishield — each dose costing Rs 157.5, including GST, according to official sources. HLL Lifecare, a PSU, has issued the supply order on behalf of the Union health ministry on March 12 in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs, at the Pune-based SII. The cost of the 10-crore doses would be borne by the health ministry.

Reportedly, the expenditure for the earlier orders of the COVID-19 vaccines was funded by PM Cares Fund, the sources added.

Previous:Maha wants to manufacture Covaxin at Haffkine: Rajesh Tope

Next:NPPA extends ceiling prices of Heparin Injection till Sept 2021

SII gets purchase order from government for 10 crore doses of Covishield

Related News

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

You may like
More>>

SII gets purchase order from government for 10 crore doses of Covishield

Related News

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

Macrogen Consortium win tender for National Bio Big Data Project

SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

You may likeMore>>

You may like
More>>